What's breaking now, across thousands of outlets.
A former congressman will take over for prominent lobbyist Steve Ubl. Elsewhere, recent buyout deals paid dividends for Mirum and AbbVie.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
President Trump's nominee for U.S. surgeon general advanced through a key Senate committee on Wednesday, setting up a glide path to a floor vote and confirmation.
MILAN — Forget Wegovy and Zepbound. Never mind CagriSema, and even retatrutide. The latest big name in obesity is eloraTZP.
The Senate Health, Education, Labor and Pensions Committee advanced President Trump's pick for the next surgeon general, sending Nicole Saphier's nomination to the full Senate.
Genetic markers in the blood that can signal lung cancer risk up to 10 years before a person is diagnosed have been discovered by University of Hawaiʻi researchers.
Even relatively small increases in fine-particle air pollution can be followed by more asthma- and chronic obstructive pulmonary disease (COPD)-related emergency department visits, according to a…
FDA elevates salad dressing recall to highest risk level over Salmonella concerns as food safety remains under scrutiny.
